Pharmaceuticals / Sleep Disorders

Lilly to Acquire Centessa Pharmaceuticals to Advance Sleep-Wake Disorder Treatments

Eli Lilly and Company is set to acquire Centessa Pharmaceuticals for a potential total of $7.8 billion. This acquisition aims to advance treatments for sleep-wake disorders by leveraging Centessa's orexin receptor 2 (OX2R) agonists, which h...

Image via Eli Lilly

Apr 01, 2026 16:00 Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders | Eli Lilly and Company

Pharmaceuticals / Weight Loss

Novo Nordisk to Take Legal Action Against Hims & Hers Over Wegovy Copy

Feb 06, 2026 01:02 Novo Nordisk says it will take legal action after Hims & Hers reveals $49 copy of Wegovy pill

Pharmaceuticals / Job Losses

Novo Nordisk to Cut 9,000 Jobs Amid Increased Competition

Sep 10, 2025 07:34 Wegovy-maker Novo Nordisk to slash 9,000 jobs as competition heats up